Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles

Kai-Wen Huang1, Shieh-Yueh Yang2,3, Yu-Wei Hong3, Jen-Jie Chieh3, Che-Chuan Yang3, Herng-Er Horng3, Chau-Chung Wu4, Chin-Yih Hong5, Hong-Chang Yang61Department of Surgery and Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University, Taipei, 2MagQu Co, Ltd, Sindian D...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Huang KW, Yang SY, Hong YW, Chieh JJ, Yang CC, Horng HE, Wu CC, Hong CY, Yang HC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/6f132fbf43be43ae9cf76f958278defa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6f132fbf43be43ae9cf76f958278defa
record_format	dspace
spelling	oai:doaj.org-article:6f132fbf43be43ae9cf76f958278defa2021-12-02T02:42:15ZFeasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles1176-91141178-2013https://doaj.org/article/6f132fbf43be43ae9cf76f958278defa2012-04-01T00:00:00Zhttp://www.dovepress.com/feasibility-studies-for-assaying-alpha-fetoprotein-using-antibody-acti-a9710https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Kai-Wen Huang1, Shieh-Yueh Yang2,3, Yu-Wei Hong3, Jen-Jie Chieh3, Che-Chuan Yang3, Herng-Er Horng3, Chau-Chung Wu4, Chin-Yih Hong5, Hong-Chang Yang61Department of Surgery and Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University, Taipei, 2MagQu Co, Ltd, Sindian Dist, New Taipei City, 3Institute of Electro-optical Science and Technology, National Taiwan Normal University, Taipei, 4Departments of Internal Medicine and Primary Care Medicine, College of Medicine, National Taiwan University, Taipei, 5Graduate Institute of Bio-medical Engineering, National Chung Hsing University, Taichung, 6Department of Physics, National Taiwan University, Taipei, TaiwanAbstract: Some previous reports have already shown the characterizations of immunomagnetic reduction (IMR). The assay technology involves the utilities of biofunctionalized magnetic nanoparticles to label target biomolecules. However, the detection threshold and interference tests for IMR have not been investigated in detail. In this study, alpha-fetoprotein (AFP) was used as a target biomolecule. The signals for AFP solutions of various concentrations, or with interfering materials, were detected via IMR. These samples were also used for characterizing the detection threshold and interference with enzyme-linked immunosorbent assay (ELISA). The results of assaying AFP level with IMR and ELISA were compared. The detection threshold for assaying AFP with IMR was found to be 3 ng/mL, which is 15 times lower than that of ELISA, and definitely suppresses false negative. For the interfering materials noted commonly in serum such as hemoglobin, bilirubin, triglyceride, and vascular endothelial growth factor, there was no detectable interfering effect when assaying AFP with IMR. Several serum samples from normal people and liver-tumor-bearing patients were used for the detections of AFP concentration via IMR. These results reveal the feasibilities of assaying AFP in blood using IMR, as well as achieving high-sensitive and high-specific assay for AFP.Keywords: immunomagnetic reduction, ELISA, biofunctionalized magnetic nanoparticlesHuang KWYang SYHong YWChieh JJYang CCHorng HEWu CCHong CYYang HCDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 1991-1996 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Huang KW Yang SY Hong YW Chieh JJ Yang CC Horng HE Wu CC Hong CY Yang HC Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
description	Kai-Wen Huang1, Shieh-Yueh Yang2,3, Yu-Wei Hong3, Jen-Jie Chieh3, Che-Chuan Yang3, Herng-Er Horng3, Chau-Chung Wu4, Chin-Yih Hong5, Hong-Chang Yang61Department of Surgery and Hepatitis Research Center, National Taiwan University Hospital, National Taiwan University, Taipei, 2MagQu Co, Ltd, Sindian Dist, New Taipei City, 3Institute of Electro-optical Science and Technology, National Taiwan Normal University, Taipei, 4Departments of Internal Medicine and Primary Care Medicine, College of Medicine, National Taiwan University, Taipei, 5Graduate Institute of Bio-medical Engineering, National Chung Hsing University, Taichung, 6Department of Physics, National Taiwan University, Taipei, TaiwanAbstract: Some previous reports have already shown the characterizations of immunomagnetic reduction (IMR). The assay technology involves the utilities of biofunctionalized magnetic nanoparticles to label target biomolecules. However, the detection threshold and interference tests for IMR have not been investigated in detail. In this study, alpha-fetoprotein (AFP) was used as a target biomolecule. The signals for AFP solutions of various concentrations, or with interfering materials, were detected via IMR. These samples were also used for characterizing the detection threshold and interference with enzyme-linked immunosorbent assay (ELISA). The results of assaying AFP level with IMR and ELISA were compared. The detection threshold for assaying AFP with IMR was found to be 3 ng/mL, which is 15 times lower than that of ELISA, and definitely suppresses false negative. For the interfering materials noted commonly in serum such as hemoglobin, bilirubin, triglyceride, and vascular endothelial growth factor, there was no detectable interfering effect when assaying AFP with IMR. Several serum samples from normal people and liver-tumor-bearing patients were used for the detections of AFP concentration via IMR. These results reveal the feasibilities of assaying AFP in blood using IMR, as well as achieving high-sensitive and high-specific assay for AFP.Keywords: immunomagnetic reduction, ELISA, biofunctionalized magnetic nanoparticles
format	article
author	Huang KW Yang SY Hong YW Chieh JJ Yang CC Horng HE Wu CC Hong CY Yang HC
author_facet	Huang KW Yang SY Hong YW Chieh JJ Yang CC Horng HE Wu CC Hong CY Yang HC
author_sort	Huang KW
title	Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
title_short	Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
title_full	Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
title_fullStr	Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
title_full_unstemmed	Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
title_sort	feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/6f132fbf43be43ae9cf76f958278defa
work_keys_str_mv	AT huangkw feasibilitystudiesforassayingalphafetoproteinusingantibodyactivatedmagneticnanoparticles AT yangsy feasibilitystudiesforassayingalphafetoproteinusingantibodyactivatedmagneticnanoparticles AT hongyw feasibilitystudiesforassayingalphafetoproteinusingantibodyactivatedmagneticnanoparticles AT chiehjj feasibilitystudiesforassayingalphafetoproteinusingantibodyactivatedmagneticnanoparticles AT yangcc feasibilitystudiesforassayingalphafetoproteinusingantibodyactivatedmagneticnanoparticles AT hornghe feasibilitystudiesforassayingalphafetoproteinusingantibodyactivatedmagneticnanoparticles AT wucc feasibilitystudiesforassayingalphafetoproteinusingantibodyactivatedmagneticnanoparticles AT hongcy feasibilitystudiesforassayingalphafetoproteinusingantibodyactivatedmagneticnanoparticles AT yanghc feasibilitystudiesforassayingalphafetoproteinusingantibodyactivatedmagneticnanoparticles
_version_	1718402225496129536

Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles

Ejemplares similares